• Hepatitis C Virus (HCV) by Molecular Method, Qualitative or Quantitative
  • Benign neoplasm, pituitary gland (pituitary adenoma)
  • Aripiprazole (Abilify), Serum
  • CTC1 Gene Mutation Analysis
  • Severe Combined Immunodeficiency (SCID)
  • Arsenic, Hair
  • Francisella tularensis Antibody, IgG, IgM
  • Malignant neoplasm of parathyroid gland (parathyroid carcinoma)
  • Gout
  • Maternal Screening, Sequential
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MPO/PR-3 (ANCA) Antibodies
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

MPO/PR-3 (ANCA) Antibodies
Medical Test

ICD10
Access to MPO/PR-3 (ANCA) Antibodies is restricted.
Loading...